A Phase III study of UBT251 Injection in adults with Type 2 Diabetes inadequately controlled by diet and exercise alone
Not Yet Recruiting Phase 3 NCT07659574
Study Description
A clinical research study testing whether a new injectable medication called UBT251 can help improve blood sugar control in adults with Type 2 Diabetes who are not achieving adequate control through diet and exercise alone
Study Details
- Registry ID:
- NCT07659574
- Conditions:
- Type 2 Diabetes
- Phase:
- Phase 3
- Target Enrollment:
- 360 participants
- Start Date:
- Age Range:
- 18–75 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
The Second Xiangya Hospital of Central South University
Hunan, Changsha, China
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.